Skip to main content

Table 3 Association of level of support offered to patients and clinical outcomes

From: Severe hyperkalemia requiring hospitalization: predictors of mortality

  Improvement in hyperkalemia In-hospital mortality
  Improvement
( n = 715)
No improvement
( n = 208)
P Death
( n = 283)
Survival
( n = 640)
P
Level of
support Ia
2.8 ± 1.8 2.2 ± 1.5 < 0.001 2.4 ± 1.5 2.7 ± 1.8 0.012
Level of
support IIb
3.1 ± 1.9 2.6 ± 1.8 < 0.001 2.9 ± 1.9 3.0 ± 1.9 0.266
  1. Values are presented as mean ± standard deviation. aDefined as the sum of weighted value for initial conservative management offered to each patient, including drug cessation (weight 1), intravenous (IV) calcium gluconate (weight 1), dextrose fluid with insulin (weight 1), IV or oral sodium bicarbonate (weight 1), calcium polystyrene sulfonate enema (weight 1), oral calcium polystyrene sulfonate (weight 1), and IV or oral loop diuretics (weight 1). bDefined as the sum of weighted value for initial conservative management and renal replacement therapy offered to each patient, including hemodialysis (weight 1) and continuous renal replacement therapy (weight 2).